Literature DB >> 2375115

[Status of tracheotomy in treatment of the respiratory emergency in anaplastic thyroid cancer].

T Hölting1, H Meybier, H Buhr.   

Abstract

A review is presented on the 69 patients requiring intraoperative tracheotomy amongst 170 patients with locally infiltrating carcinoma of the thyroid operated on over a 30-year period. 55% of these patients underwent this procedure for absolute indications; in 45% of cases it was performed as a prophylactic procedure to prevent later respiratory complications due to further infiltration by the anaplastic tumour. The follow-up showed that there was no benefit for patients with anaplastic neoplasms from this additional procedure. Most of these patients suffered from local wound healing complications so that obligatory postoperative external radiation could not be administered. The overall prognosis was very poor. Survival was significantly lower still in the group of patients in whom tracheotomy had been performed.

Entities:  

Mesh:

Year:  1990        PMID: 2375115

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  4 in total

Review 1.  Surgical options in undifferentiated thyroid carcinoma.

Authors:  Brian Hung-Hin Lang; Chung-Yau Lo
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

Review 2.  New trends in the treatment of undifferentiated carcinomas of the thyroid.

Authors:  Paolo Miccoli; Gabriele Materazzi; Alessandro Antonelli; Erica Panicucci; Gianluca Frustaci; Piero Berti
Journal:  Langenbecks Arch Surg       Date:  2006-11-28       Impact factor: 2.895

Review 3.  The Role of Tracheostomy in Anaplastic Thyroid Carcinoma.

Authors:  Jia Xu; Zhen Liao; Jing-Jia Li; Xi-Fu Wu; Shi-Min Zhuang
Journal:  World J Oncol       Date:  2015-02-14

4.  Treatment and prognosis of anaplastic thyroid carcinoma: experience from a single institution in China.

Authors:  Chuanzheng Sun; Qiuli Li; Zedong Hu; Jiehua He; Chao Li; Guojun Li; Xiaofeng Tao; Ankui Yang
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.